Published in Med Parazitol (Mosk) on February 23, 1979
[Human dirofilariasis in the Moscow region]. Med Parazitol (Mosk) (2003) 0.87
[Human echinococcosis: the role of histocompatibility antigens in realizing infestations and the characteristics of their course]. Med Parazitol (Mosk) (1994) 0.86
[The distribution of the HLA antigen system among patients with echinococcosis]. Med Parazitol (Mosk) (1990) 0.86
[Interferon status and the HLA antigen system. 1. Unilocular echinococcosis]. Med Parazitol (Mosk) (1992) 0.84
[Clonorchiasis in the People's Republic of Vietnam. 2. The clinico-parasitological examination of a focus and a trial of prazinquantel treatment]. Med Parazitol (Mosk) (1992) 0.83
Vascular endothelial growth factor in tumor tissue and blood serum from patients with breast cancer. Bull Exp Biol Med (2003) 0.80
[The efficacy of the mebendazole treatment of patients with hydatid disease]. Med Parazitol (Mosk) (1994) 0.80
[Dirofilariasis in the Moscow Region, a low disease transmission risk area]. Med Parazitol (Mosk) (2011) 0.79
[Clinical importance of hemolysis in the prophylactic treatment of malaria using primaquine on persons with a glucose-6-phosphate dehydrogenase deficit]. Med Parazitol (Mosk) (1975) 0.79
[Clinical trial of the possibility of increasing the bioavailability of mebendazole using sunflower oil in echinococcosis]. Med Parazitol (Mosk) (1989) 0.78
[Results of studies of human dirofilariasis in Russia]. Med Parazitol (Mosk) (2014) 0.77
[Use of mebendazole in a mixture with sunflower seed oil (pharmacokinetic research)]. Med Parazitol (Mosk) (1989) 0.77
[Combined radiotherapy for inoperable esophageal cancer]. Vopr Onkol (2006) 0.77
[Clinico-parasitological research in a mixed focus of clonorchiasis and intestinal nematodiasis in Hanamnin Province (the Socialist Republic of Vietnam)]. Med Parazitol (Mosk) (1990) 0.76
[The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1. The tolerance and efficacy of different doses of biltricide during outpatient use in foci]. Med Parazitol (Mosk) (1995) 0.76
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer. Bull Exp Biol Med (2007) 0.76
[Opisthorchiasis and alcoholism: a clinico-epidemiological and social psychology study]. Med Parazitol (Mosk) (1990) 0.76
[Vascular endothelial growth factor and plasminogen activators in endometrial carcinoma and hyperplasia]. Vopr Onkol (2003) 0.75
[Combined endoscopic monitoring of treatment effectiveness in tracheal and/or bronchial malignancies using autofluorescence spectroscopy]. Vopr Onkol (2010) 0.75
[Conservative treatment of locally advanced and inoperable esophageal cancer: possible methods and future directions]. Vopr Onkol (2012) 0.75
[An experience with argon-plasma coagulation in endoscopic management of obstructive tumors of the trachea and main bronchi]. Vopr Onkol (2004) 0.75
[Medico-statistical and economic assessment of the health indices of the local population in an endemic focus of opisthorchiasis]. Med Parazitol (Mosk) (1986) 0.75
[Diagnosis of opisthorchiasis using the membrane filtration technique]. Lab Delo (1990) 0.75
[Results of endoscopic recanalization for inoperable cancer of the esophagus]. Vopr Onkol (2005) 0.75
[The clinical efficacy of and tolerance for lariam (mefloquine) in tropical malaria in the south of the Socialist Republic of Vietnam]. Med Parazitol (Mosk) (1991) 0.75
[The morphological changes in the small intestine of cats with metagonimiasis]. Med Parazitol (Mosk) (1992) 0.75
[The incidence of opisthorchiasis and diseases of the duodeno-choledocho-pancreatic organs and their correlation with the quantitative parameters of the expulsion of Opisthorchis felineus eggs. 1. The opisthorchiasis morbidity of a local Khanty-Mansisk population]. Med Parazitol (Mosk) (1986) 0.75
[The subfractional composition of the blood plasma in benign tumors and cancer of the breast based on the data from laser correlational spectroscopy]. Biull Eksp Biol Med (1993) 0.75
[ENDOSCOPIC MUCOSAL RESECTION AND ENDOSCOPIC DISSECTION IN THE SUBMUCOSAL LAYER FOR EARLY GASTRIC CANCER]. Vopr Onkol (2015) 0.75
[Comprehensive assessment of an opisthorchiasis focus in the Komi-Permiak Autonomous Okrug]. Med Parazitol (Mosk) (1989) 0.75
[An experience with stenting the esophagus in patients with inoperable cancer]. Vestn Khir Im I I Grek (2004) 0.75
[The mebendazole treatment of patients with alveolar echinococcosis]. Med Parazitol (Mosk) (1994) 0.75
[Praziquantel and other current preparations and chemotherapy methods in human trematodiases of the liver (opisthorchiasis and clonorchiasis) (a review of the literature)]. Med Parazitol (Mosk) (1985) 0.75
[An analysis of 4 strategies for the praziquantel treatment of persons infested with Opisthorchis felineus under conditions excluding reinfestation]. Med Parazitol (Mosk) (1989) 0.75
[The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale]. Med Parazitol (Mosk) (1993) 0.75
[Use of plant oils to increase the bioavailability of mebendazole (in a model of larval unilocular echinococcosis)]. Med Parazitol (Mosk) (1987) 0.75
[Efficacy and tolerance of treatment of echinococcosis patients (Echinococcus granulosus, Echinococcus multilocularis) with mebendazole]. Med Parazitol (Mosk) (1987) 0.75
[Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer]. Vopr Onkol (2003) 0.75
[Complex endoscopy-assisted treatment for pleural malignancies with concomitant exudative pleuritis]. Vopr Onkol (2009) 0.75
[Use of hypotensive anesthesia in endotracheo-bronchial surgery for tumor-related lesion of the trachea and/or central bronchi]. Vopr Onkol (2010) 0.75
[Hemocoagulation disturbances in drug-provoked hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]. Probl Gematol Pereliv Krovi (1976) 0.75
[Combantrin effectiveness and tolerance in intestinal nematodiases]. Med Parazitol (Mosk) (1980) 0.75
[2. Opisthorchiasis and diphyllobothriasis morbidity in the native population of the Kyshik settlement, Khanty-Mansi Autonomous Okrug]. Med Parazitol (Mosk) (1986) 0.75
[New Soviet anthelmintic medamine: the results of clinical trials in intestinal nematodiases]. Med Parazitol (Mosk) (1987) 0.75
[Radionuclide and sonographic diagnosis of lesions of the hepatobiliary system in opisthorchiasis]. Med Parazitol (Mosk) (1990) 0.75
[The histocompatibility system and its significance in parasitology]. Med Parazitol (Mosk) (1989) 0.75
[The value of intraluminal brachytherapy in the treatment for esophageal cancer]. Vopr Onkol (2015) 0.75
[Method of analysing the quantitative parameters of an Opisthorchis felineus infestation. 2. The quantitative diagnosis of opisthorchiasis by determining the confidence limits for the basic parameters]. Med Parazitol (Mosk) (1984) 0.75
[Agranulocytosis--a complication of the chemotherapy of echinococcosis with mebendazole]. Med Parazitol (Mosk) (1993) 0.75
[Mini-invasive technologies in complex treatment of esophagus cancer]. Khirurgiia (Mosk) (2015) 0.75
[Use of endoscopic surgery and combined radiotherapy for inoperable cancer of the esophagus]. Vopr Onkol (2006) 0.75
[An analysis of opisthorchiasis and diphyllobothriasis morbidity of the local and native populations in endemic foci by 3 exponential models with a determination of the epidemic potential]. Med Parazitol (Mosk) (1988) 0.75
[Application of automated quantitative cytometry in diagnosis of lung cancer]. Vopr Onkol (2011) 0.75
[Initial experience with using praziquantel for treating persons infected with Opisthorchis felineus in the acute and chronic stages of the disease]. Med Parazitol (Mosk) (1986) 0.75
[MINIMALLY INVASIVE ESOPHAGECTOMY]. Vopr Onkol (2015) 0.75
[Endoscopic argon-plasma coagulation and combined radiotherapy for short (up to 3 cm) esophageal cancers]. Vopr Onkol (2005) 0.75
[Use of coagulograph H-333 in the diagnosis of drug-induced hemolysis]. Sov Med (1975) 0.75
[Initial experience in the use of praziquantel on an outpatient basis in a focus of opisthorchiasis in the Ukrainian SSR]. Med Parazitol (Mosk) (1988) 0.75
[Conservative therapy of echinococcal disease: optimization of the mebendazole dosage regimen using a computer]. Med Parazitol (Mosk) (1988) 0.75
[Anesthesiological care of fiber colonoscopy in cancer patients]. Anesteziol Reanimatol (2001) 0.75
[The clinico-epidemiological characteristics of opisthorchiasis foci in the Yamalo-Nenets Autonomous Okrug and the treatment results with praziquantel]. Med Parazitol (Mosk) (1992) 0.75
[Intestinal trematodiases (metagonimiasis, nanophyetiasis): clinico-parasitological research and the first trial of using Azinox in a focus of the lower Amur River valley]. Med Parazitol (Mosk) (1992) 0.75
[Ca++ ion transport blockers as reversants of the drug resistance of malarial parasites. 1. The effect of verapamil on the resistance to chloroquine in vivo of Plasmodium berghei and in vitro of Plasmodium falciparum]. Med Parazitol (Mosk) (1996) 0.75
[An experience with clinical endoscopy and argon-plasma coagulation for removal of large bowel polyps]. Vopr Onkol (2005) 0.75
[Immediate and long-term results of brachytherapy in complex treatment for esophageal cancer]. Vopr Onkol (2014) 0.75
[Quantitative diagnosis of opisthorchiasis and other human helminthiases using a modified Kato method]. Med Parazitol (Mosk) (1983) 0.75
[The interferon status in helminthiases. 2. Alveolar hydatid disease]. Med Parazitol (Mosk) (1991) 0.75
[Hemostatic system disorders in malaria (a review of the literature)]. Med Parazitol (Mosk) (1981) 0.75
[Pharmacokinetics of mebendazole in man]. Med Parazitol (Mosk) (1987) 0.75
[Video thoracoscopy in the diagnosis and treatment of pulmonary, mediastinal and pleural neoplasia]. Vopr Onkol (2002) 0.75
[Opisthorchiasis in the Moscow and Vladimir regions]. Med Parazitol (Mosk) (1989) 0.75
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]. Vopr Onkol (2004) 0.75
["Second-look" surgery and diagnostic laparoscopy in the combined and comprehensive therapy of patients with ovarian cancer]. Vopr Onkol (1998) 0.75
[Improved high-frequency flow ventilation-assisted endotracheobronchial surgery for tumors of the trachea and main bronchi]. Vopr Onkol (2009) 0.75
[Prasiquantel treatment of patients under ambulatory conditions in an opisthorchiasis focus in the Komi-Permyak autonomous area]. Med Parazitol (Mosk) (1989) 0.75
[Treatment with Vermox of trichinosis from natural strains in Sakhalin]. Med Parazitol (Mosk) (1982) 0.75
[Opisthorchiasis and diphyllobothriasis morbidity of the population in the settlement of Vanzetur, Khanty-Mansi National Okrug]. Med Parazitol (Mosk) (1987) 0.75
[Factors affecting the effectiveness of opisthorchiasis chemotherapy. I. The treatment of opisthorchiasis in the early stage of the disease]. Med Parazitol (Mosk) (1980) 0.75
[Concurrent chemoradiotherapy with moderate dose brachytherapy as remission induction for patients surgically treated for esophageal cancer]. Vopr Onkol (2012) 0.75
[Correlation of the clinical and parasitological effectiveness in the chloxyl treatment of opisthorchiasis]. Med Parazitol (Mosk) (1983) 0.75
[Use of general anesthesia during fiber colonoscopy in cancer patients]. Vopr Onkol (2002) 0.75
[Analysis of the causes of opisthorchiasis treatment failure in a focus of invasion]. Med Parazitol (Mosk) (1987) 0.75
[Factors affecting the effectiveness of chemotherapy in opisthorchiasis. II. Treatment of opisthorchiasis in the chronic stage]. Med Parazitol (Mosk) (1981) 0.75
[Clinical laboratory indices of hemolysis in persons with various types of haptoglobin in preventive primaquine therapy of malaria]. Med Parazitol (Mosk) (1975) 0.75
[The molecular mechanism responsible for the adaptation of malignant tumors to hormonal drugs: a role of phophatidylinositol-3-kinase and phosphoinositide-dependent proteins]. Vestn Ross Akad Med Nauk (2004) 0.75
[The role of transcription factor Snail1 in the regulation of hormonal sensitivity of in vitro cultured breast cancer cells]. Vopr Onkol (2012) 0.75
[Endoscopic possibilities in the palliative treatment of cardial gastroesophageal cancer]. Vopr Onkol (2005) 0.75
[Vascular endothelial growth factor and two types of its receptors in breast cancer]. Vopr Onkol (2005) 0.75
[Filtration methods in the diagnosis of human tropical helminthiases (trematodiasis, intestinal nematodiasis and filariasis) (a review of the literature)]. Med Parazitol (Mosk) (1986) 0.75
[Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis]. Med Parazitol (Mosk) (1987) 0.75
[Intraluminal endoscopic surgery in prevention and palliation of dysphagia induced by esophageal cancer (methods, technique and immediate results)]. Vopr Onkol (2004) 0.75
[The efficacy of and tolerance for fansimef in the treatment of tropical malaria in the south of the Socialist Republic of Vietnam]. Med Parazitol (Mosk) (1990) 0.75
[Use of autofluorescence bronchoscopy and spectrometry in the diagnosis of central lung cancer]. Vopr Onkol (2011) 0.75
[The 85th anniversary of N. N. Petrov Research Institute of Oncology]. Vopr Onkol (2012) 0.75
[Clinical assessment of immunoglobulin E in the blood and the level of circulating immune complexes in parasitic diseases. 3. Opisthorchiasis]. Med Parazitol (Mosk) (1990) 0.75
[Method of analyzing the quantitative parameters of human Opisthorchis felineus infection. 1. An analysis of the law of the distribution of O. felineus eggs excreted with the feces]. Med Parazitol (Mosk) (1984) 0.75
[The interferon status in helminthiases. 1. Human unilocular hydatid disease]. Med Parazitol (Mosk) (1990) 0.75
[Endoscopic ultrasonography (EUS) in gastrointestinal neoplasms]. Vopr Onkol (2009) 0.75
[The level of the eosinophils in the blood, serum immunoglobulins and circulating immune complexes and interferon production in patients with unilocular echinococcosis depending on the location of the cysts]. Med Parazitol (Mosk) (1994) 0.75
[Hemolytic stability of erythrocyte membranes in patients with tropical malaria]. Med Parazitol (Mosk) (1987) 0.75